As of 2025-07-09, the Relative Valuation of Thalys Medical Technology Group Inc (603716.SS) is (50.06) CNY. This relative valuation is based on P/E multiples. With the latest stock price at 21.19 CNY, the upside of Thalys Medical Technology Group Inc based on Relative Valuation is -336.3%.
The range of the Relative Valuation is (46.45) - (47.93) CNY.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 33.0x | 29.2x |
| Forward P/E multiples | 20.1x - 24.7x | 22.4x |
| Fair Price | (46.45) - (47.93) | (50.06) |
| Upside | -319.2% - -326.2% | -336.3% |
| Date | P/E |
| 2025-07-08 | -10.92 |
| 2025-07-07 | -11.61 |
| 2025-07-04 | -10.86 |
| 2025-07-03 | -9.87 |
| 2025-07-02 | -8.98 |
| 2025-07-01 | -8.16 |
| 2025-06-30 | -7.42 |
| 2025-06-27 | -7.17 |
| 2025-06-26 | -7.00 |
| 2025-06-25 | -6.99 |
| 2025-06-24 | -6.92 |
| 2025-06-23 | -6.89 |
| 2025-06-20 | -6.26 |
| 2025-06-19 | -6.39 |
| 2025-06-18 | -6.76 |
| 2025-06-17 | -6.98 |
| 2025-06-16 | -6.57 |
| 2025-06-13 | -6.41 |
| 2025-06-12 | -6.88 |
| 2025-06-11 | -6.88 |
| 2025-06-10 | -6.94 |
| 2025-06-09 | -6.31 |
| 2025-06-06 | -6.28 |
| 2025-06-05 | -6.31 |
| 2025-06-04 | -6.47 |
| 2025-06-03 | -6.69 |
| 2025-05-30 | -6.46 |
| 2025-05-29 | -6.58 |
| 2025-05-28 | -6.18 |
| 2025-05-27 | -6.23 |
| 2025-05-26 | -5.97 |
| 2025-05-23 | -6.16 |
| 2025-05-22 | -5.60 |
| 2025-05-21 | -5.78 |
| 2025-05-20 | -5.76 |
| 2025-05-19 | -5.73 |
| 2025-05-16 | -5.75 |
| 2025-05-15 | -5.72 |
| 2025-05-14 | -5.93 |
| 2025-05-13 | -6.02 |
| 2025-05-12 | -5.75 |
| 2025-05-09 | -5.65 |
| 2025-05-08 | -5.95 |
| 2025-05-07 | -5.91 |
| 2025-05-06 | -5.72 |
| 2025-04-30 | -5.51 |
| 2025-04-29 | -5.30 |
| 2025-04-28 | -4.82 |
| 2025-04-25 | -5.31 |
| 2025-04-24 | -4.82 |